Image: kff.org · rights & removal
Executive Summary
Facts Only
* The average monthly Part D premium is estimated to increase by only $1, from $35 to $36, for most enrollees in 2027.
* The number of stand-alone PDPs available to the average beneficiary will fall from 11 in 2026 to 9 in 2027.
* PDP availability in 2027 varies by state, ranging from 8 PDPs in 15 states to 12 PDPs in 1 state.
* Enrollees in six of the eight national Part D plans continuing in 2027 will see premium reductions in some states if they keep their current plan.
* Enrollees in many other states face higher premiums for the same plans if they do not switch.
* No zero premium PDPs will be available for Part D enrollees without low-income subsidies (LIS) in 2027.
* Twenty-eight percent of PDP enrollees without LIS, or 4 million enrollees, paid no monthly premium in 2026 and will face higher premiums in 2027 regardless of plan choice.
* Specific premium increases are noted for certain plans: Humana Basic Rx PDP enrollees may face increases of $6.30 to $30.60 per month; Wellcare Value Script enrollees may face monthly increases of $5.30; and AARP Medicare Rx Saver enrollees may face an increase of $10.30 per month.
* Centene offers the lowest premiums, with 2027 monthly premiums at $5.30 for Wellcare Value Script in 45 states and $7.30 for Wellcare Classic in 33 states.
* Enrollees in United’s AARP-branded PDPs may face monthly premium increases of $50 or more in many states if they keep their current plan.
Full Take
From the original · KFF (Health Policy)
The Centers for Medicare & Medicaid Services (CMS) has just released information about Medicare Part D plans for 2027, including plan availability and premiums for the coming year. The agency emphasized stability in the Part D prescription drug plan (PDP) marketplace for 2027 (as it did for 2026) and estimated only a modest $1 increase in the average monthly PDP premium from $35 to $36.Read the full story at kff.org
Sentinel — Human
The text presents complex regulatory data in a synthesized manner, showing features consistent with expert analysis rather than raw AI generation. It effectively uses figures to build an argument about risk and choice for the reader.
